ALLIANCEBERNSTEIN L.P. - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q2 2024$2,721,995
+88.9%
243,470
+11.5%
0.00%0.0%
Q1 2024$1,441,242
+70.0%
218,370
+16.4%
0.00%
Q4 2023$847,952
+26.3%
187,6000.0%0.00%
Q3 2023$671,608
-3.0%
187,6000.0%0.00%
Q2 2023$692,244
+88.1%
187,600
+68.7%
0.00%
Q1 2023$368,072
-14.7%
111,2000.0%0.00%
Q4 2022$431,456
+285.2%
111,200
+141.7%
0.00%
Q3 2022$112,000
+124.0%
46,000
+82.5%
0.00%
Q2 2022$50,000
-65.3%
25,200
-69.3%
0.00%
Q1 2021$144,000
-10.6%
82,000
-0.8%
0.00%
Q4 2020$161,000
-37.8%
82,700
-23.8%
0.00%
Q3 2020$259,000
-52.2%
108,500
-41.3%
0.00%
Q2 2020$542,000
+107.7%
184,900
+104.3%
0.00%
Q1 2020$261,000
+177.7%
90,500
+283.5%
0.00%
Q4 2019$94,000
-10.5%
23,6000.0%0.00%
Q3 2019$105,000
+15.4%
23,6000.0%0.00%
Q2 2019$91,00023,6000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Prosight Management, LP 883,214$1,722,0000.80%
Telemetry Investments, L.L.C. 200,615$391,0000.66%
Perceptive Advisors 16,584,802$32,340,0000.35%
Consonance Capital Management LP 1,558,290$3,039,0000.28%
683 Capital Management, LLC 2,000,000$3,900,0000.18%
ESSEX INVESTMENT MANAGEMENT CO LLC 627,931$1,224,0000.15%
GSA CAPITAL PARTNERS LLP 327,052$638,0000.10%
APOGEM CAPITAL LLC 54,240$106,0000.07%
HUSSMAN STRATEGIC ADVISORS, INC. 82,000$160,0000.04%
J. Goldman & Co LP 376,319$734,0000.04%
View complete list of ADMA BIOLOGICS INC shareholders